Blurbs

Analysts Are Neutral on Top Healthcare Stocks: Universal Health (UHS), Regeneron (REGN)

Analysts fell to the sidelines weighing in on Universal Health (UHSResearch Report) and Regeneron (REGNResearch Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Universal Health (UHS)

In a report issued on June 30, Ben Hendrix from RBC Capital maintained a Hold rating on Universal Health, with a price target of $130.00. The company’s shares closed last Friday at $105.97, close to its 52-week low of $98.89.

According to TipRanks.com, Hendrix has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -10.0% and a 29.5% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Brookdale Senior Living, and Bright Health Group.

Currently, the analyst consensus on Universal Health is a Hold with an average price target of $123.38, which is a 22.9% upside from current levels. In a report issued on June 16, Loop Capital Markets also initiated coverage with a Hold rating on the stock with a $115.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Regeneron (REGN)

In a report issued on June 30, Brian Abrahams from RBC Capital maintained a Hold rating on Regeneron, with a price target of $638.00. The company’s shares closed last Friday at $595.40.

According to TipRanks.com, Abrahams is a 1-star analyst with an average return of -1.9% and a 44.9% success rate. Abrahams covers the Healthcare sector, focusing on stocks such as Intra-Cellular Therapies, Karyopharm Therapeutics, and Vertex Pharmaceuticals.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Regeneron with a $678.13 average price target, implying a 15.4% upside from current levels. In a report issued on June 17, Morgan Stanley also maintained a Hold rating on the stock with a $610.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on UHS:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos